HTR2B and congenital bilateral aplasia of vas deferens from CFTR mutation: This study reveals that genetic ablation of Htr2b attenuates hemodynamic development of CAVD in the Notch1+/- mice, but pharmacological antagonism may require high doses or long-term treatment to slow progression.